Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O15305: Variant p.Asp223Glu

Phosphomannomutase 2
Gene: PMM2
Feedback?
Variant information Variant position: help 223
Type of variant: help LP/P [Disclaimer]
Residue change: help From Aspartate (D) to Glutamate (E) at position 223 (D223E, p.Asp223Glu).
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and acidic.
BLOSUM score: help 2
Variant description: help In CDG1A; normal activity but lower affinity for alpha-D-mannose 1-phosphate.
Other resources: help


Sequence information Variant position: help 223
Protein sequence length: help 246
Location on the sequence: help TIYFFGDKTMPGGNDHEIFT D PRTMGYSVTAPEDTRRICEL
Residue conservation: help
Human                         TIYFFGDKTMPGGNDHEIFTDPR-TMGYSVTAPEDTRRICEL

Mouse                         TIYFFGDKTMPGGNDHEIFTDPR-TVGYTVTAPEDTRRICE

Bovine                        TIYFFGDKTMPGGNDHEIFTDPR-TVGYTVAAPEDTRRICE

Slime mold                    TLYFFGDKTFLGGNDYEIANHPRITQSFTVKSPANTLAILN

Sequence annotation in neighborhood: help
TypePositionsDescription
Chain 2 – 246 Phosphomannomutase 2
Binding site 209 – 209
Binding site 221 – 221
Binding site 223 – 223
Binding site 226 – 226
Alternative sequence 120 – 246 Missing. In isoform 2.



Literature citations
Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.
Kjaergaard S.; Skovby F.; Schwartz M.;
Eur. J. Hum. Genet. 6:331-336(1998)
Cited for: VARIANTS CDG1A ARG-117 AND GLU-223; Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli.
Kjaergaard S.; Skovby F.; Schwartz M.;
Eur. J. Hum. Genet. 7:884-888(1999)
Cited for: VARIANT CDG1A GLY-192; CHARACTERIZATION OF VARIANTS CDG1A ARG-117; LEU-119; HIS-141; GLY-192; GLU-223 AND ARG-237; Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
Matthijs G.; Schollen E.; Bjursell C.; Erlandson A.; Freeze H.; Imtiaz F.; Kjaergaard S.; Martinsson T.; Schwartz M.; Seta N.; Vuillaumier-Barrot S.; Westphal V.; Winchester B.;
Hum. Mutat. 16:386-394(2000)
Cited for: VARIANTS CDG1A TYR-9; CYS-11; ARG-32; ALA-44; TYR-65; MET-67; SER-69; CYS-76; LYS-101; PHE-103; CYS-106; VAL-108; LEU-113; ARG-117; LEU-119; THR-120; GLN-123; MET-129; ALA-131; ASN-132; THR-132; LYS-139; HIS-141; ASN-148; GLY-151; THR-153; SER-157; TRP-162; VAL-172; ARG-175; SER-183; GLY-185; GLY-188; GLY-192; ARG-195; SER-206; ALA-208; ILE-216; SER-216; GLU-217; LEU-218; GLU-223; SER-226; ARG-228; CYS-228; SER-229; MET-231; THR-233; ARG-237; MET-237; GLY-238 AND SER-241; VARIANT ALA-197; PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
Bjursell C.; Erlandson A.; Nordling M.; Nilsson S.; Wahlstroem J.; Stibler H.; Kristiansson B.; Martinsson T.;
Hum. Mutat. 16:395-400(2000)
Cited for: VARIANTS CDG1A TYR-9; CYS-11; MET-67; LEU-113; ARG-117; LEU-119; GLN-123; MET-129; HIS-141; VAL-172; ARG-175; SER-183; GLY-185; GLY-192; SER-216; GLU-217; GLU-223; ARG-228; MET-231 AND ARG-237;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.